Stock EXALT RESOURCES LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Exalt Resources Ltd Share Price Australian S.E.

Equities

AU000000ERD3

Advanced Medical Equipment & Technology

End-of-day quote Australian S.E.
Other stock markets
- AUD - Intraday chart for Exalt Resources Ltd
05-22 MedAdvisor to Deliver Maiden Profit in Fiscal 2024; Shares Jump 14% MT
04-24 MedAdvisor Operating Revenue Rises 42% to AU$24.2 Million in March Quarter MT
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 121M 80.19M 6.33B Sales 2025 * 144M 94.98M 7.5B Capitalization 242M 160M 12.63B
Net income 2024 * - 0 0 Net income 2025 * 3M 1.98M 156M EV / Sales 2024 * 1.92 x
Net cash position 2024 * 8.75M 5.78M 456M Net cash position 2025 * 15.05M 9.94M 785M EV / Sales 2025 * 1.58 x
P/E ratio 2024 *
657 x
P/E ratio 2025 *
94.2 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 60.73%
More Fundamentals * Assessed data

Latest news about Exalt Resources Ltd

MedAdvisor to Deliver Maiden Profit in Fiscal 2024; Shares Jump 14% MT
MedAdvisor Operating Revenue Rises 42% to AU$24.2 Million in March Quarter MT
MedAdvisor's Gross Profit Climbs 48.5% in Fiscal Q3, Revenue Rises 42.4% MT
MedAdvisor Reports Higher Attributable Profit, Revenue in Fiscal H1 MT
MedAdvisor Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Charac Limited announced that it expects to receive £1 million in funding from MedAdvisor Limited CI
MedAdvisor Secures Scope of Practice Pilot Contract; Shares Decline 3% MT
MedAdvisor Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Concerns of Further US Fed Rate Hikes Drag Australian Shares to One-Week Low MT
MedAdvisor to Reduce Australian Staff by 20% MT
MedAdvisor Limited Provides Revenue Guidance for the Fiscal Year 2023 CI
MedAdvisor Limited Announces Board Changes CI
Medadvisor Limited Announces Resignation of RaeAnn Grossman as Non-Executive Director CI
MedAdvisor Limited Announces Appointment of Anshu Raghuvanshi as Company Secretary CI
MedAdvisor Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
More news

Analyst Recommendations on Exalt Resources Ltd

Concerns of Further US Fed Rate Hikes Drag Australian Shares to One-Week Low MT
More recommendations

Press releases Exalt Resources Ltd

MedAdvisor : Update - Proposed issue of securities - MDR PU
MedAdvisor : Application for quotation of securities - MDR PU
MedAdvisor : MDR to acquire GuildLink & undertakes capital raise PU
MedAdvisor : Investor Presentation GuildLink Acquisition & Capital Raise PU
MedAdvisor : Quarterly Report and Appendix 4C PU
More press releases

Managers and Directors - Exalt Resources Ltd

Managers TitleAgeSince
Richard Ratliff CEO
 Chief Executive Officer - 14/07/22
Ancila Desai DFI
 Director of Finance/CFO - 16/10/22
Craig Schnuriger CTO
 Chief Tech/Sci/R&D Officer - 29/06/20
Members of the board TitleAgeSince
Linda Jenkinson CHM
 Chairman - 27/02/22
Kevin Hutchinson BRD
 Director/Board Member - 22/11/22
Richard Ratliff CEO
 Chief Executive Officer - 14/07/22
More insiders

Company Profile

MedAdvisor Limited is an Australia-based company that is engaged in digital medication adherence solutions. The Company's segments include Australia, the United States, the United Kingdom and Asia Operations. The Company's products suite includes Medication Management Application, PlusOne Pharmacy Software and Pharma Patient Experience Platform. The Medication Management Application connects to the pharmacy from the mobile phone. The Company's subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam UK Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.
Sector
Advanced Medical Equipment & Technology
Calendar
28/08/2024 - Q4 2024 Earnings Release (Projected)
More about the company

Sector Medical Software & Technology Services

1st Jan change Capi.
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
-4.06% 29.86B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+39.10% 9.06B
SECTRA AB Stock Sectra AB
+39.47% 4.55B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-34.39% 2.49B
VERADIGM INC. Stock Veradigm Inc.
-14.11% 1.52B
OMNICELL, INC. Stock Omnicell, Inc.
-25.83% 1.28B
LUNIT INC. Stock Lunit Inc.
-38.46% 1.05B
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+4.27% 932M
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-41.98% 809M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. MDR Stock
  4. Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW